Total Payments
$6,760
2024 Payments
$264.90
Companies
52
Transactions
359
Medicare Patients
1,651
Medicare Billing
$144,832
Payment Breakdown by Category
Food & Beverage$6,730 (99.5%)
Education$30.64 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,730 | 357 | 99.5% |
| Education | $30.64 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Collegium Pharmaceutical, Inc. | $1,150 | 53 | $0 (2024) |
| Boston Scientific Corporation | $776.63 | 23 | $0 (2022) |
| Abbott Laboratories | $452.69 | 11 | $0 (2021) |
| Sentynl Therapeutics, Inc. | $340.63 | 24 | $0 (2019) |
| Daiichi Sankyo Inc. | $299.54 | 31 | $0 (2019) |
| Nevro Corp. | $298.73 | 9 | $0 (2024) |
| BioDelivery Sciences International, Inc. | $291.78 | 19 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $290.00 | 17 | $0 (2023) |
| Medtronic USA, Inc. | $271.24 | 8 | $0 (2017) |
| ASSERTIO THERAPEUTICS, Inc. | $214.20 | 11 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $264.90 | 12 | Collegium Pharmaceutical, Inc. ($68.02) |
| 2023 | $557.27 | 21 | Collegium Pharmaceutical, Inc. ($269.00) |
| 2022 | $488.75 | 26 | Collegium Pharmaceutical, Inc. ($128.00) |
| 2021 | $658.96 | 36 | Collegium Pharmaceutical, Inc. ($176.28) |
| 2020 | $544.20 | 25 | Boston Scientific Corporation ($121.46) |
| 2019 | $1,235 | 64 | Boston Scientific Corporation ($222.55) |
| 2018 | $1,277 | 98 | Daiichi Sankyo Inc. ($176.83) |
| 2017 | $1,734 | 77 | Abbott Laboratories ($397.08) |
All Payment Transactions
359 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Virtus Pharmaceuticals LLC | LEVORPHANOL TARTRATE (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: ANALGESICS - OPIOID | ||||||
| 12/04/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $24.45 | General |
| 11/13/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Analgesic | ||||||
| 07/29/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $22.95 | General |
| Category: Opioid Analgesic | ||||||
| 07/01/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/29/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/09/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $24.00 | General |
| Category: Opioid Analgesic | ||||||
| 05/02/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/01/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 02/21/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $30.56 | General |
| Category: PAIN | ||||||
| 02/15/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $21.07 | General |
| Category: Opioid Analgesic | ||||||
| 01/18/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/01/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $24.11 | General |
| Category: Opioid Analgesic | ||||||
| 10/18/2023 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: PAIN | ||||||
| 10/06/2023 | Azurity Pharmaceuticals, Inc. | Horizant (Drug) | Food and Beverage | Cash or cash equivalent | $20.12 | General |
| Category: Sleep | ||||||
| 09/27/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $24.92 | General |
| Category: Opioid Analgesic | ||||||
| 08/23/2023 | Forte Bio-Pharma LLC | PROLATE (Drug), NALOCET, PROLATE | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: PAIN | ||||||
| 08/17/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $24.18 | General |
| Category: Opioid Analgesic | ||||||
| 07/06/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.34 | General |
| Category: Opioid Analgesic | ||||||
| 06/01/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Gastroenterology | ||||||
| 05/25/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: Opioid Analgesic | ||||||
| 05/04/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $23.64 | General |
| Category: Opioid Analgesic | ||||||
| 04/12/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $20.55 | General |
| Category: Opioid Analgesic | ||||||
| 03/31/2023 | EAGLE PHARMACEUTICALS, INC. | BYFAVO (Drug) | Food and Beverage | In-kind items and services | $137.60 | General |
| Category: Anesthesiology | ||||||
| 03/29/2023 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $15.65 | General |
| Category: Pain Management | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 258 | 368 | $149,508 | $23,142 |
| 2022 | 11 | 375 | 496 | $220,303 | $33,507 |
| 2021 | 12 | 431 | 563 | $266,476 | $41,702 |
| 2020 | 19 | 587 | 719 | $334,582 | $46,481 |
Total Patients
1,651
Total Services
2,146
Medicare Billing
$144,832
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 98 | 176 | $49,794 | $11,421 | 22.9% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 36 | 46 | $20,404 | $4,083 | 20.0% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 37 | 50 | $47,276 | $3,691 | 7.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 34 | 37 | $6,216 | $1,462 | 23.5% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 14 | 18 | $17,263 | $1,448 | 8.4% |
| 00142 | Anesthesia for lens surgery | Facility | 2023 | 18 | 19 | $7,575 | $771.37 | 10.2% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 21 | 22 | $979.44 | $266.56 | 27.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 89 | 132 | $37,345 | $8,663 | 23.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 70 | 100 | $41,696 | $8,414 | 20.2% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2022 | 33 | 49 | $21,734 | $4,371 | 20.1% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2022 | 42 | 56 | $52,949 | $4,296 | 8.1% |
| 01402 | Anesthesia for procedure for total knee joint replacement | Facility | 2022 | 20 | 20 | $25,275 | $2,719 | 10.8% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2022 | 13 | 17 | $16,304 | $1,328 | 8.1% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2022 | 22 | 23 | $9,150 | $1,158 | 12.7% |
| 00142 | Anesthesia for lens surgery | Facility | 2022 | 24 | 25 | $10,050 | $1,056 | 10.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 19 | 22 | $3,696 | $947.98 | 25.6% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 32 | 33 | $1,469 | $393.27 | 26.8% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 11 | 19 | $633.08 | $160.76 | 25.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 95 | 154 | $64,212 | $15,325 | 23.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 80 | 119 | $33,667 | $6,894 | 20.5% |
| 62323 | Injection of substance into spinal canal of lower back or sacrum using imaging guidance | Facility | 2021 | 64 | 74 | $69,968 | $5,837 | 8.3% |
| 64483 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance, single level | Facility | 2021 | 28 | 34 | $15,081 | $3,151 | 20.9% |
| 01402 | Anesthesia for open or endoscopic total knee joint replacement | Facility | 2021 | 18 | 18 | $22,650 | $2,503 | 11.1% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Facility | 2021 | 39 | 39 | $15,600 | $2,015 | 12.9% |
| 01214 | Anesthesia for open total hip joint replacement | Facility | 2021 | 13 | 14 | $19,200 | $1,987 | 10.3% |
About Dr. Patrick Laguerre, M.D
Dr. Patrick Laguerre, M.D is a Pain Medicine healthcare provider based in Mooresville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1336324193.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Laguerre, M.D has received a total of $6,760 in payments from pharmaceutical and medical device companies, with $264.90 received in 2024. These payments were reported across 359 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($6,730).
As a Medicare-enrolled provider, Laguerre has provided services to 1,651 Medicare beneficiaries, totaling 2,146 services with total Medicare billing of $144,832. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Other Specialties Interventional Pain Medicine, Anesthesiology
- Location Mooresville, NC
- Active Since 12/29/2007
- Last Updated 06/09/2020
- Taxonomy Code 208VP0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1336324193
Products in Payments
- XTAMPZA (Drug) $909.76
- GENERAL - PAIN MANAGEMENT (Device) $371.26
- SCS IPGs (Device) $275.22
- Morphabond ER (Drug) $268.75
- Levorphanol (Drug) $267.25
- RELISTOR (Drug) $262.41
- TARGETSTIM (Device) $247.06
- GENERAL PAIN MANAGEMENT (Device) $215.88
- Senza Spinal Cord Stimulation System (Device) $214.17
- Qutenza (Drug) $211.89
- BUNAVAIL 2.1 mg 30-count box (Drug) $162.74
- Xtampza ER (Drug) $158.98
- Horizant (Drug) $155.46
- Gralise (Drug) $142.96
- BYFAVO (Drug) $137.60
- BELBUCA (Drug) $129.04
- LYRICA (Drug) $113.66
- SPRIX (Drug) $107.59
- OXYCONTIN (Drug) $104.31
- SPECTRA WAVEWRITER (Device) $102.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.